Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
HPV16-E7-T512 (1 trial)
docetaxel (taxotere) (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
pembrolizumab (keytruda) (1 trial)
ttx-030 (1 trial)
Lymphoma (Phase 1)
Uterine Cervical Neoplasms (Phase 3)
Trials (2 total)
Trial APIs (6 total)